Company / SG&A per Share
Ovid Therapeutics Inc. SG&A per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.36
FY2025
5-year range
$0.36 / $0.53
FY2022-FY2025
Trend
-17.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has declined for 3 consecutive years, from $0.53 in FY2022 to $0.36 in FY2025.
Based on SEC 10-K filings.
0.36 in FY2025 with a 3-year CAGR of -11.9%.
Improved from $0.46 to $0.36 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -11.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Ovid Therapeutics Inc.'s sg&a per share has declined for 3 consecutive years.
- In FY2025, sg&a per share decreased 17.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.36 | -17.7% |
| FY2024 | $0.44 | -4.5% |
| FY2023 | $0.46 | -13.0% |
| FY2022 | $0.53 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026